Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Carboxy Methyl Lysine Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Carboxy Methyl Lysine in EIA, WB, IHC (fro), IF und IHC (p). Er zeigt eine Reaktivität gegenüber .
Produktnummer ABIN1105660

Kurzübersicht für Carboxy Methyl Lysine Antikörper (ABIN1105660)

Target

Alle Carboxy Methyl Lysine (CML) Antikörper anzeigen
Carboxy Methyl Lysine (CML)

Wirt

  • 1
  • 1
Maus

Klonalität

  • 1
  • 1
Monoklonal

Konjugat

  • 2
Dieser Carboxy Methyl Lysine Antikörper ist unkonjugiert

Applikation

Enzyme Immunoassay (EIA), Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

CML26
  • Kreuzreaktivität (Details)

    Species reactivity (tested):Human, Multispecies cross reactant.

    Aufreinigung

    Protein G Chromatography

    Immunogen

    Carboxy Methyl Lysine (CML)-KLH

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % Sodium Azide, 0.1 % BSA

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store undiluted at 2-8 °C.
  • Target

    Carboxy Methyl Lysine (CML)

    Andere Bezeichnung

    Carboxy Methyl Lysine

    Substanzklasse

    Amino Acid

    Hintergrund

    CML is known to be formed from the oxidation of both carbohydrates and lipids. This makes CML a biomarker of general oxidative stress. Carboxymethyl-lysine (CML) is a well-characterized glycoxidation product that accumulates in tissues with age, and its rate of accumulation is accelerated in diabetes. Glycoxidation products are a subset of advanced glycation endproducts (AGEs) that are formed by the nonenzymatic glycation and subsequent irreversible oxidation of proteins. Oxidative stress and protein modification have been implicated in the pathogenesis of the chronic complications of diabetes, including nephropathy and atherosclerosis. The accumulation of CML in long-lived tissue such as skin collagen reflects oxidative stress over an extended period of the life-span, and has been shown to be greater in patients with diabetic complications than those without complications.Synonyms: CML, Carboxymethyl-lysine
Sie sind hier:
Chat with us!